Our findings of reduced OSCP levels and the interaction of Aβ with OSCP, which impair mitochondrial function in AD-related pathological settings, implicate that Aβ toxicity induces OSCP aberrations, leading to mitochondrial F1FO-ATP synthase dysfunction in AD-sensitive brain areas. Here, ATP5PO is linked to Alzheimer disease.